当前位置:首页 > 研究报告 > 医疗健康 > 大健康 > Investigation & Investment Forecast Report on China Big Health Industry During 2019-2023

Investigation & Investment Forecast Report on China Big Health Industry During 2019-2023

中国投资咨询网www.ocn.com.cn2018/11/20
  • 首次出版:   最新修订:November 2018
  • 交付方式:特快专递(2-3天送达)
  • 报告属性:共207页、7.3万字、83个图表
  • 中文版全价:RMB8900 印刷版:RMB8600 电子版:RMB8600
  • 英文版全价:USD6800 印刷版:USD5800 电子版:USD5800
  • 定购电话:0755-82571522、82571566、400-008-1522
  • 24小时服务热线:138 0270 8576
中投顾问咨询服务大健康产业咨询解决方案>>>
中投顾问以"挖掘产业投资机会,促进区域经济发展"为己任,发展起以产业研究为坚实根基,以产业规划、招商服务为重点,以中投大数据为创新方向的业务体系,十余年间累计服务政企客户数万家。

Chapter I: Concept and Industrial Chain of the Big Health Industry
1.1: Definition of the industry
1.2: Industrial group composition
1.3: Composition of the industrial chain
Chapter II: Comprehensive Analysis of the Big Health Industry between 2016 and 2018
2.1: Overall analysis of the international big health industry between 2016 and 2018
2.1.1: Analysis of industry development scale
2.1.2: Regional distribution pattern of the industry
2.1.3: Industrial investment and merger and acquisition
2.1.4: Future development trend of the industry
2.2: Background of the development of the big health industry in China
2.2.1: The importance of industry development
2.2.2: Analysis of demand for industrial development
2.2.3: Industry becoming blue sea for corporate investments
2.3: Policy environment for the big health industry in China
2.3.1: Summary of favorable policies
2.3.2: Outline of Industrial Development Planning
2.4: Analysis of development status of the big health industry in China between 2016 and 2018
2.4.1: Analysis of industrial structure
2.4.2: Status of the industrial scale
2.4.3: Analysis of industrial profit
2.4.4: Industry competition pattern
2.4.5: Spatial layout features
2.4.6: Industry development trend
2.4.7: Market expansion situation
2.5: Analysis of problems facing the development of the big health industry in China
2.5.1: Analysis of impeding factors
2.5.2: Analysis of development bottleneck
2.5.3: Insufficient innovation capacity
2.5.4: Gap with overseas
2.6: Suggestions for the development of China's big health industry
2.6.1: Recommendations for policy development
2.6.2: Development promotion strategy
2.6.3: Recommendations for innovation mode
Chapter III: Analysis of Development Hot Spots of the Big Health Industry in China between 2016 and 2018
3.1: Medical treatment of “Internet +”
3.1.1: Market operation status
3.1.2: Mobile medical market
3.1.3: Online medical market
3.1.4: Smart medical market
3.1.5: Market development trend
3.2: Market of big medical data
3.2.1: Background of market development
3.2.2: Analysis of the market size
3.2.3: Market competition pattern
3.2.4: Market demand analysis
3.3: Integrated medical care and endowment service mode
3.3.1: Summary of supporting policies
3.3.2: Development status of the mode
3.3.3: Problems and proposals
3.3.4: Future development prospect
3.4: Medical beauty industry
3.4.1: Overview of the development of the industry
3.4.2: Current market size
3.4.3: Market share distribution
3.4.4: Investment status
3.5: Medical tourism industry
3.5.1: Relevant summary
3.5.2: Market development scale
3.5.3: Analysis of key elements
3.5.4: Analysis of investment opportunities
3.5.5: Future prospect
3.6: Gene sequencing industry
3.6.1: Current market size
3.6.2: Analysis of application fields
3.6.3: Investment scale of the industry
3.6.4: Industrial investment opportunities
3.7: Chinese medicine big health industry
3.7.1: Current development status
3.7.2: Problems facing the industrial development
3.7.3: Opportunities for industry development
3.7.4: Industry development strategy
Chapter IV: Development and Investment Potential Analysis of Segmented Industries of the Big Health Industry in China between 2019 and 2023
4.1: The Pharmaceutical industry
4.1.1: Analysis of the development status
4.1.2: Investment scale
4.1.3: Investment potential analysis
4.1.4: Industrial prospect
4.2: Medical appliance industry
4.2.1: Industrial scale
4.2.2: Investment boom analysis
4.2.3: Industry investment situation
4.2.4: Analysis of investment opportunities
4.2.5: Analysis of investment hot spots
4.2.6: Key development areas in the future
4.3: Medical service industry
4.3.1: Development status
4.3.2: Analysis of the investment opportunities
4.3.3: Analysis of investment prospect
4.3.4: Investment timing and sectors
4.3.5: Investment sector pattern
4.4: Health management services
4.4.1: Current market scale
4.4.2: Market demand and supply trend
4.4.3: Industry development opportunities
4.4.4: Industry development potential
4.4.5: Industry investment hot spots
4.5: Health endowment service industry
4.5.1: Market development space
4.5.2: Analysis of investment opportunities
4.5.3: Layout of enterprises’ investments
4.5.4: Prospect of industry development
4.5.5: Industrial development trend
Chapter V: Development Status of the Big Health Industry in Some Regions between 2016 and 2018
5.1: Analysis of development of big health industry in Guizhou Province
5.1.1: Status of industrial development
5.1.2: Industrial structure analysis
5.1.3: Investment trend of the industry
5.1.4: Industry development goals
5.2: Analysis of development of health industry in Zhejiang Province
5.2.1: Basis of the industrial development
5.2.2: Operation status of the industry
5.2.3: Regional development trend
5.2.4: Analysis of industrial policies
5.3: Analysis of development of big health industry in Hainan Province
5.3.1: Development advantages
5.3.2: Summary of current status
5.3.3: Analysis of industrial scale
5.3.4: Analysis of industrial prospect
5.3.5: Industrial development planning
5.4: Analysis of development of big health industry in Jilin Province
5.4.1: Analysis of industrial scale
5.4.2: Construction of development platform
5.4.3: Major development goals
5.4.4: Key areas of industrial development
Chapter VI: Analysis of Competitiveness of Key Enterprises in the Big Health Industry between 2016 and 2018
6.1: Tasly Pharmaceutical Group Co., Ltd.
6.1.1: Overview of corporate development
6.1.2: Analysis of business performance
6.1.3: Business operation analysis
6.1.4: Future prospect
6.2: Yunnan Baiyao Group Co., Ltd.
6.2.1: Development overview
6.2.2: Business performance
6.2.3: Business operation analysis
6.2.4: Future prospect
6.3: Jiangzhong Pharmaceutical Co., Ltd.
6.3.1: Development overview
6.3.2: Business performance analysis
6.3.3: Business operation analysis
6.3.4: Future prospect
6.4: Beijing Tongrentang Co., Ltd.
6.4.1: Development overview
6.4.2: Business performance analysis
6.4.3: Business operation analysis
6.4.4: Future prospect
6.5: China Resources Sanjiu Medical and Pharmaceutical Co., Ltd.
6.5.1: Development overview
6.5.2: Business performance analysis
6.5.3: Business operation analysis
6.5.4: Core competitiveness analysis
6.5.5: Future prospect
6.6: Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.
6.6.1: Development overview
6.6.2: Business performance analysis
6.6.3: Business operation analysis
6.6.4: Future prospect
Chapter VII: Dynamic Statistics and Analysis of the Big Health Industry by CIC between 2016 and 2018
7.1: Market status of investment and financing of the big health industry between 2016 and 2018
7.1.1: Investment and financing scale
7.1.2: Sector-wise distribution of financing
7.1.3: M&A market situation
7.1.4: IPO financing scale
7.2: Investment and financing of segments of the big health industry
7.2.1: The hospital field
7.2.2: Medicine enterprises
7.2.3: Medical appliance
7.2.4: Medicine e-commerce
Chapter VIII: Analysis of Investment Potential and Risk Warning of the Big Health Industry between 2016 and 2018
8.1: Analysis of investment opportunities of the big health industry
8.1.1: Industrial investment characteristics
8.1.2: Industrial policy opportunities
8.1.3: Industrial investment opportunity
8.1.4: Industrial investment direction
8.1.5: Industry investment opportunities
8.2: Risks of and proposals for the investment and financing in big health industry
8.2.1: Analysis of investment risks
8.2.2: Analysis of financing modes
8.2.3: Proposals and analysis of investment and financing
Chapter IX: Analysis of Development Prospect and Trend of the Big Health Industry between 2019 and 2023 by CIC
9.1: Forecast of development prospect of the big health industry
9.1.1: Industry development prospect
9.1.2: Industrial development opportunities
9.2: Analysis of development trend of the big health industry
9.2.1: Industrial development trend
9.2.2: Operation mode in the future
9.2.3: Consumerization trend
9.3: Forecast and analysis of the big health industry between 2019 and 2023 by CIC
9.3.1: Factors affect the industrial development
9.3.2: Forecast of the industry scale

  • 图表目录
  •  

Table 1 differences between the big health industry and the traditional healthcare industry
Table 2 Composition of industrial chain of the big health industry
Table 3 Trend of the global big health industry between 2007 and 2015
Table 4 Regional distribution pattern of the global big health industry in 2015
Table 5 Statistics of major regional big health industry globally between 2007 and 2015
Table 6 Comparison of top 10 M&A transactions of the global pharmaceutical industry between 2012 and 2016
Table 7 Major policies concerning the big health industry launched in 2016
Table 8 Industrial structure chart of the big health industry of the US
Table 9 Industrial structure chart of the big health industry of China
Table 10 Change trend of revenue from main business of pharmacy manufacturing industry between 2012 and 2016
Table 11 Number of pharmacy manufacturing enterprises in China between 2012 and 2016
Table 12 Profit rate of medical appliances of China between 2011 and 2015
Table 13 Trend of profitability of the pharmaceutical industry in China between 2012 and 2016
Table 14 Basic composition of mobile medical chain
Table 15 Architecture of industrial chain of mobile medical market
Table 16 Trend of mobile medical value in China between 2011 and 2016
Table 17 Major profit model of online medical
Table 18 Market size changes of health big data industry in China between 2010 and 2015
Table 19 Competition pattern of the domestic health big data industry
Table 20 Relevant supporting policies for integrated medical care between 2013 and 2015
Table 21 Development history of medical cosmetology
Table 22 Scale of medical cosmetology in China between 2011 and 2015
Table 23 Ratios of medical plastic surgery in 2010 and 2015
Table 24 Statistics of investments in medical beauty industry of China between 1998 and 2016
Table 25 Distribution of industrial investment stage of the medical cosmetology industry of China between 1998 and (based on number of investment cases)
Table 26 Distribution of industrial investment stage of the medical cosmetology industry of China between 1998 and (based on investment amount)
Table 27 Investment round distribution of medical appliance industry in China between 1998 and 2016 (based on investment cases)
Table 28 Investment round distribution of medical appliance industry in China between 1998 and 2016 (based on investment amount)
Table 29 Composition of medical tourism industry
Table 30 Medical tourism market size of China between 2010 and 2014
Table 31 Global gene sequencing market size between 2007 and 2022
Table 32 Major application fields of gene sequencing
Table 33 Proportions of major applications of global gene sequencing market
Table 34 Analysis of financing of the gene sequencing industry in China between 2006 and 2017
Table 35 Change of a single financing scale of the gene sequencing industry in China between 2006 and 2017
Table 36 Analysis of financing main bodies of gene sequencing industry in China between 2016 and 2017
Table 37 Financing rounds distribution of China's genetic sequencing industry between 2016 and 2017
Table 38 The distribution of financing fields of China's gene sequencing industry in 2017
Table 39 Main business revenue of the pharmaceutical industry y in 2016
Table 40 Markets size of medical appliance market of China between 2007 and 2016
Table 41 Medical service expenditure scale trend in China between 2011 and 2015
Table 42 Health services investment opportunities and risks
Table 43 Analysis of investment sectors of medical service industry
Table 44 Keys of high-end medical services
Table 45 Successful private specialized chain hospital requirements
Table 46 Future investment trends in medical services
Table 47 The core success factor of comprehensive hospitals
Table 48 The market size and the growth rate of China's health management industry between 2009 and 2014
Table 49 Ratios of populations aged 60 and 65 above in China between 2010 and 2040
Table 50 Implementation of key big health projects in 2016
Table 51 Ranking of Chinese patented medicine of Guizhou in China and comparison with other provinces in China in 2015
Table 52 Classified added values of the health industry in Hangzhou in 2015
Table 53 Total and net assets of Tasly Group between 2016 and 2018
Table 54 Business revenue and net profit of Tasly Group between 2015 and 2016
Table 55 Business revenue and net profit of Tasly Group in 2017
Table 56 Main business revenue of Tasly Group in terms of industry, product and region in 2016
Table 57 Total and net assets of Yunnan Baiyao Group between 2016 and 2018
Table 58 Business revenue and net profit of Yunnan Baiyao Group between 2015 and 2016
Table 59 Business revenue and net profit of Yunnan Baiyao Group between in 2017
Table 60 Industry, product and region-wise main business revenues of Yunnan Baiyao Group in 2016
Table 61 Total and net assets of Jiangzhong Pharmaceutical Co., Ltd. between 2016 and 2018
Table 62 Business revenue and net profit of Jiangzhong Pharmaceutical Co., Ltd. between 2015 and 2016
Table 63 Business revenue and net profit of Jiangzhong Pharmaceutical Co., Ltd. in 2017
Table 64 Industry, product and region-wise main business revenues of Jiangzhong Pharmaceutical Co., Ltd. in 2016
Table 65 Total and net assets of Beijing Tongrentang between 2016 and 2018
Table 66 Business revenue and net profit of Beijing Tongrentang between 2015 and 2016
Table 67 Business income and net profit of Beijing Tongrentang in 2017
Table 68 Industry and region-wise main business income of Beijing Tongrentang in 2016
Table 69 Total and net assets of China Resources Sanjiu between 2016 and 2018
Table 70 Business revenue and net profit of China Resources Sanjiu between 2015 and 2016
Table 71 Business revenue and net profit of China Resources Sanjiu in 2017
Table 72 Industry, product and region-wise main business revenue of China Resources Sanjiu in 2016
Table 73 Total and net assets of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. between 2016 and 2018
Table 74 Business revenue and net profit of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. between 2015 and 2016
Table 75 Business revenue and net profit of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. in 2017
Table 76 Industry, product and region-wise main business revenue of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. in 2016
Table 77 VC/PE financing of the health industry in China between 2011 and 2016
Table 78 VC/PE financing distribution of segments of the domestic medical and health industry in 2016
Table 79 Declared and completed M&A transaction trend in the medical and health industry between 2011 and 2016
Table 80 IPO financing scale of the medical and health industry in China between 2011 and 2016
Table 81 Return on exit trend of IPO in the medical and health industry between 2011 and 2016
Table 82 Number and amount of M&A of medicine enterprises between 2012 and 2016
Table 83 Forecast of the health industry scale of China between 2019 and 2023 by CIC

***************更多图表目录略***************
本报告目录与内容系中投顾问原创,未经中投顾问书面许可及授权,拒绝任何形式的复制、转载,谢谢!
购买流程
温馨提示
    1. 购买报告时请认准"中投顾问"商标,公司从未通过第三方代理,请与本站电话联系购买。
    2. 中投顾问欢迎广大客户上门洽谈与合作,您可以上门浏览报告核实后付款。
购买此报告的用户还购买了
联系我们
研究报告热线:
规划咨询热线:
招商咨询热线:
节日值班电话:
深圳总部地址:
0755-82571522
400 008 1522
400 008 0552
400 008 0586
138 0270 8576
广东省深圳市福田区车公庙泰然六路雪松大厦A座4楼
在线咨询: 点击这里给我发消息